Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Guardant Health, Parse Biosciences, Menarini Silicon Biosystems

Guardant Health Guardant Reveal

Guardant Health has launched Guardant Reveal, a blood-based liquid biopsy test for the detection of residual and recurrent disease in cancer patients. Intended initially for the early-stage colorectal cancer space, the assay detects circulating tumor DNA in patients' blood to identify those with residual disease who may benefit most from adjuvant therapy and/or detect the first signs of a recurrence. Results are returned in as little as seven days without the need for a tissue biopsy.


Parse Biosciences Single-Cell Whole Transcriptome Kit

Parse Biosciences, formerly known as Split Biosciences, has launched its Single-Cell Whole Transcriptome kit in North America.

The kit, which requires only basic lab equipment, enables single-cell transcriptomics for up to 100,000 cells or nuclei across 48 samples. Samples can be fixed for up to six months prior to barcoding and sequencing. The method is based on the split-pool ligation-based transcriptome sequencing (SPLiT-seq) method. Customers purchasing the kit will receive access to the Parse computational pipeline, an out-of-the box software tool that can be run locally.


Menarini Silicon Biosystems CellMag Product Line

Menarini Silicon Biosystems has launched its CellMag product line. The line includes the CTC Epithelial Cell kit for ferrofluid-based EpCAM-positive circulating tumor cell enrichment, a magnetic tool, and consumables. The firm believes the product line will help researchers conduct specific, established, and standardized immunomagnetic enrichment and staining of CTCs in peripheral blood. After positive selection of enriched cells, performed by capturing cells through ferrofluids labeled with antibodies targeting specific antigens, the staining procedure delivers cells that are ready for enumeration, isolation, and downstream analysis. Menarini said the CellMag line provides researchers with a manual system using the same ferrofluid technology offered by its CellSearch system.


For more new products and services, please visit the New Products page on our website.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.